Shopping Cart
- Remove All
- Your shopping cart is currently empty
DSR-6434 is a selective agonist of TLR7 with antitumor effect. DSR-6434 exhibits EC50s of 7.2 nM and 4.6 nM for human and mouse.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $58 | In Stock | |
10 mg | $105 | In Stock | |
25 mg | Inquiry | In Stock | |
1 mL x 10 mM (in DMSO) | $58 | In Stock |
Description | DSR-6434 is a selective agonist of TLR7 with antitumor effect. DSR-6434 exhibits EC50s of 7.2 nM and 4.6 nM for human and mouse. |
Targets&IC50 | TLR7:4.6 nM (EC50, Mice), TLR7:7.2 nM (EC50, Human) |
In vitro | To evaluate the specificity of DSR-6434 for TLR7, a NF-κB-driven reporter assay was conducted in HEK293 cells engineered to express hTLR7, TLR8, or TLR9. This assay determines specificity through NF-κB activation upon successful receptor binding. Results demonstrate that DSR-6434 selectively stimulates reporter gene activity in cells expressing hTLR7, but not in those expressing the structurally similar hTLR8 or hTLR9[1]. |
In vivo | In B6C3F1 mice, DSR-6434 (0.1-1 mg/kg; i.v.) significantly suppresses lung metastasis[1]. |
Molecular Weight | 400.48 |
Formula | C19H28N8O2 |
Cas No. | 1059070-10-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 225 mg/mL (561.8 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.